
- Pharmaceutical Executive-06-01-2008
- Volume 0
- Issue 0
Roger Adsett, Shire
S
Roger Adsett
VP and General Manager, Gastroenterology, Shire
NOTED FOR: Strong leadership, building blockbuster brands
VISION: "Explain it so others internalize—not recite—it"
Roger Adsett knows big brands. He cut his teeth at Astra Merck, heading up marketing for Nexium, then moved to England to serve as global brand director for AstraZenica's Symbicort. Now re-settled in the Northeast corridor, he's translating marketing savvy and global know-how to Shire's GI business—with good results. Last year's launch of Lialda sent business soaring, without cannibalizing Pentasa sales. Shire brands now serve more than a quarter of the oral mesalamine market. And with a co-promotion deal signed with TAP, Adsett will bring his blockbuster mindset to the realm of specialty sales.
Roger Adsett
Articles in this issue
almost 18 years ago
Mary Szela, Abbottalmost 18 years ago
Mightier Than the Swordalmost 18 years ago
Keeshia Muhammad, Teva Specialty Pharmaceuticalsalmost 18 years ago
Eric Floyd, Cephalonalmost 18 years ago
Nancy Phelan, Wyethalmost 18 years ago
Tightening the Chainalmost 18 years ago
Kurt Graves, Vertexalmost 18 years ago
Wendy Niebler, Shirealmost 18 years ago
Perfectly ImperfectNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.




